Reducing immunosuppressant use in patients with chronic inflammation during the COVID‐19 pandemic: Risks versus benefits
Saved in:
Main Authors: | Mariko Ogawa‐Momohara (Author), Yoshinao Muro (Author), Takuya Takeichi (Author), Masashi Akiyama (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ANCA‐associated neuropathy in systemic sclerosis: A case report and review of literature
by: Kayo Takenaka, et al.
Published: (2021) -
Late‐onset Langerhans cell histiocytosis without extracutaneous involvement
by: Mai Iwata, et al.
Published: (2020) -
Paradoxical Reaction in a Patient with Hidradenitis Suppurativa Undergoing Adalimumab Treatment
by: Soichiro Ikeya, et al.
Published: (2021) -
Two Cases of Porokeratosis with MVD Mutations, in Association with Bullous Pemphigoid
by: Yuki Arisawa, et al.
Published: (2021) -
Abscopal Effect of Local Irradiation Treatment for Diffuse Large B-cell Lymphoma
by: Yuri Hidaka, et al.
Published: (2017)